• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

风湿云应用程序:一款用于管理中国风湿病患者的新型移动应用程序。

RheumCloud App: A Novel Mobile Application for the Management of Rheumatic Diseases Patients in China.

作者信息

Huang Can, Zhao Jiuliang, Tian Xinping, Wang Qian, Xu Dong, Li Mengtao, Zeng Xiaofeng

机构信息

Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences and Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science and Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH); Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China.

出版信息

Rheumatol Immunol Res. 2022 Dec 31;3(4):184-189. doi: 10.2478/rir-2022-0033. eCollection 2022 Dec.

DOI:10.2478/rir-2022-0033
PMID:36879841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9984926/
Abstract

This review summarizes the history, function, application, and achievement of the RheumCloud App as a novel smartphone application. This App reflects the development of the Chinese Rheumatism Data Center (CRDC), which provides not only a technical platform for the database and registry of rheumatic diseases (RDs) in China, but also a close tie between Chinese rheumatologists and patients with RDs. Throughout the past decade, CRDC has successfully built the world's largest nationwide database for RDs. A total of 2074 tertiary referral centers consisting of 8051 rheumatologists participated in the registry. RheumCloud App, which is representative of the success of CRDC, has played a central role in supporting patient cohort registration, biosample collection, and patient education. Based on the data of the Rhuem-Cloud App, three national key research projects have been funded and a series of research papers have been published.

摘要

本综述总结了RheumCloud应用程序作为一款新型智能手机应用的历史、功能、应用及成果。该应用反映了中国风湿病数据中心(CRDC)的发展,它不仅为中国风湿病数据库和登记系统提供了技术平台,还紧密联系了中国风湿病学家和风湿病患者。在过去十年中,CRDC成功建立了世界上最大的全国性风湿病数据库。共有由8051名风湿病学家组成的2074个三级转诊中心参与了登记。代表CRDC成功的RheumCloud应用程序在支持患者队列登记、生物样本采集和患者教育方面发挥了核心作用。基于RheumCloud应用程序的数据,三项国家重点研究项目获得资助,一系列研究论文得以发表。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37f8/9984926/23c65e6b12fa/rir-03-184-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37f8/9984926/3a7cdb988043/rir-03-184-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37f8/9984926/49be5671d18c/rir-03-184-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37f8/9984926/23c65e6b12fa/rir-03-184-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37f8/9984926/3a7cdb988043/rir-03-184-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37f8/9984926/49be5671d18c/rir-03-184-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37f8/9984926/23c65e6b12fa/rir-03-184-g003.jpg

相似文献

1
RheumCloud App: A Novel Mobile Application for the Management of Rheumatic Diseases Patients in China.风湿云应用程序:一款用于管理中国风湿病患者的新型移动应用程序。
Rheumatol Immunol Res. 2022 Dec 31;3(4):184-189. doi: 10.2478/rir-2022-0033. eCollection 2022 Dec.
2
CRDC: a Chinese rheumatology research platform.CRDC:一个中国风湿病学研究平台。
Clin Rheumatol. 2015 Aug;34(8):1347-52. doi: 10.1007/s10067-015-3003-1. Epub 2015 Jul 11.
3
Evaluating Chinese Mobile Health Apps for Ankylosing Spondylitis Management: Systematic App Search.评估用于强直性脊柱炎管理的中文移动医疗应用程序:系统应用搜索。
JMIR Mhealth Uhealth. 2021 Jul 14;9(7):e27234. doi: 10.2196/27234.
4
An automated structured education intervention based on a smartphone app in Chinese patients with type 1 diabetes: a protocol for a single-blinded randomized controlled trial.基于智能手机应用程序的针对中国 1 型糖尿病患者的自动化结构化教育干预:一项单盲随机对照试验方案。
Trials. 2020 Nov 23;21(1):944. doi: 10.1186/s13063-020-04835-9.
5
Effectiveness of an app-based intervention for unintentional injury among caregivers of preschoolers: protocol for a cluster randomized controlled trial.基于应用程序的学龄前儿童照顾者意外伤害干预效果的研究方案:一项群组随机对照试验。
BMC Public Health. 2018 Jul 11;18(1):865. doi: 10.1186/s12889-018-5790-1.
6
German Mobile Apps in Rheumatology: Review and Analysis Using the Mobile Application Rating Scale (MARS).德国风湿病学移动应用程序:使用移动应用程序评级量表(MARS)进行的评估与分析。
JMIR Mhealth Uhealth. 2019 Aug 5;7(8):e14991. doi: 10.2196/14991.
7
Assessment of Mobile Health Apps Using Built-In Smartphone Sensors for Diagnosis and Treatment: Systematic Survey of Apps Listed in International Curated Health App Libraries.利用内置智能手机传感器进行诊断和治疗的移动健康应用评估:国际精选健康应用程序库中列出的应用程序的系统调查。
JMIR Mhealth Uhealth. 2020 Feb 3;8(2):e16741. doi: 10.2196/16741.
8
Optimising epilepsy management with a smartphone application: a randomised controlled trial.使用智能手机应用优化癫痫管理:一项随机对照试验。
Med J Aust. 2020 Apr;212(6):258-262. doi: 10.5694/mja2.50520. Epub 2020 Feb 24.
9
Mobile Application to Promote Adherence to Oral Chemotherapy and Symptom Management: A Protocol for Design and Development.促进口服化疗依从性和症状管理的移动应用程序:设计与开发方案
JMIR Res Protoc. 2017 Apr 20;6(4):e62. doi: 10.2196/resprot.6198.
10
Mobile Responsive App-A Useful Additional Tool for Data Collection in the German Pregnancy Register Rhekiss?移动响应式应用程序——德国妊娠登记处Rhekiss数据收集的有用辅助工具?
Front Med (Lausanne). 2021 Dec 17;8:773836. doi: 10.3389/fmed.2021.773836. eCollection 2021.

引用本文的文献

1
Identifying Parameters Associated with Delayed Diagnosis in Thrombotic Antiphospholipid Syndrome: Data from China Prospective APS Cohort.确定与血栓形成性抗磷脂综合征延迟诊断相关的参数:来自中国抗磷脂综合征前瞻性队列的数据。
Adv Ther. 2025 Aug 19. doi: 10.1007/s12325-025-03317-1.
2
The distinct subtypes and prognosis of acute myocardial infarction in antiphospholipid syndrome patients.抗磷脂综合征患者急性心肌梗死的不同亚型及预后
Clin Rheumatol. 2025 Aug 18. doi: 10.1007/s10067-025-07624-4.
3
Risk stratification and subgroup analysis of systemic lupus erythematosus patients with pregnancy: based on a 13-year multicenter cohort study.

本文引用的文献

1
Rheumatology in 2049: the age of .2049年的风湿病学:……时代
Ann Rheum Dis. 2021 Jul;80(7):825-827. doi: 10.1136/annrheumdis-2020-219686. Epub 2021 Feb 9.
2
Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis.中国类风湿关节炎注册研究(CREDIT):I. 中国类风湿关节炎患者缓解的介绍和流行率。
Clin Exp Rheumatol. 2018 Sep-Oct;36(5):836-840. Epub 2018 Mar 21.
3
CRDC: a Chinese rheumatology research platform.CRDC:一个中国风湿病学研究平台。
系统性红斑狼疮患者妊娠的风险分层与亚组分析:基于一项13年的多中心队列研究
Clin Rheumatol. 2025 Aug 12. doi: 10.1007/s10067-025-07552-3.
4
Impact of antiphospholipid antibodies on heart valve involvements in systemic lupus erythematosus: based on CSTAR cohort.抗磷脂抗体对系统性红斑狼疮心脏瓣膜受累的影响:基于中国系统性红斑狼疮研究协作组(CSTAR)队列研究
Lupus Sci Med. 2025 Jun 19;12(1):e001674. doi: 10.1136/lupus-2025-001674.
5
Future atherosclerotic cardiovascular disease in systemic lupus erythematosus based on CSTAR (XXVIII): the effect of different antiphospholipid antibodies isotypes.基于中国系统性红斑狼疮研究协作组(CSTAR)(XXVIII)的系统性红斑狼疮患者未来动脉粥样硬化性心血管疾病:不同抗磷脂抗体亚型的影响
BMC Med. 2025 Jan 6;23(1):8. doi: 10.1186/s12916-024-03843-9.
6
Tacrolimus shows adequate efficacy in patients with antiphospholipid antibodies associated thrombocytopenia: a retrospective cohort study.他克莫司治疗抗磷脂抗体相关血小板减少症患者的疗效观察:一项回顾性队列研究。
Clin Exp Med. 2023 Dec;23(8):5433-5443. doi: 10.1007/s10238-023-01248-1. Epub 2023 Nov 6.
Clin Rheumatol. 2015 Aug;34(8):1347-52. doi: 10.1007/s10067-015-3003-1. Epub 2015 Jul 11.
4
Chinese SLE Treatment and Research group (CSTAR) registry: I. Major clinical characteristics of Chinese patients with systemic lupus erythematosus.中国系统性红斑狼疮研究协作组(CSTAR)登记研究:一、中国系统性红斑狼疮患者的主要临床特征。
Lupus. 2013 Oct;22(11):1192-9. doi: 10.1177/0961203313499086. Epub 2013 Aug 20.